Home > Balance Sheet > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Total Non-Current Liabilities

    Back to Balance Sheet
KILITCH DRUGS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

KILITCH DRUGS (INDIA) Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹25 Cr₹-2.39 Cr₹-1.91 Cr₹-1.24 Cr₹-0.90 Cr

What is the latest Total Non-Current Liabilities ratio of KILITCH DRUGS (INDIA) ?

The latest Total Non-Current Liabilities ratio of KILITCH DRUGS (INDIA) is ₹25 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹25 Cr
Mar2024₹-2.39 Cr
Mar2023₹-1.91 Cr
Mar2022₹-1.24 Cr
Mar2021₹-0.90 Cr

How is Total Non-Current Liabilities of KILITCH DRUGS (INDIA) Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹25 Cr
Positive
Mar2024 ₹-2.39 Cr
Negative
Mar2023 ₹-1.91 Cr
Negative
Mar2022 ₹-1.24 Cr
Negative
Mar2021 ₹-0.90 Cr -

Compare Total Non-Current Liabilities of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹454.7 Cr -3.6% -20.9% -26.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,083.0 Cr -3.9% -8.9% -3.2% Stock Analytics
DIVIS LABORATORIES ₹163,971.0 Cr 3.8% -4.7% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,660.0 Cr 3.2% -5.6% 26.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,686.0 Cr 3.3% -6% 11% Stock Analytics
CIPLA ₹99,086.7 Cr 0.8% -9.1% -13.1% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

-3.6%

-20.9%

-26.5%

SENSEX

4.7%

-0.1%

3.6%


You may also like the below Video Courses